
|Articles|July 13, 2023
Safety, Containment, and Analysis of Highly Potent Compounds From Development to Commercialization
Author(s)Curia
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup–July 10, 2026
2
The FDA Moves to Modernize Drug Manufacturing Registration
3
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
4
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
5